View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Softigel by Procaps
11 April 2018

Join Softigel at CPhI

Softigel by Procaps will be attending CPhi North America´s second edition once again.

Its team of experts will be delighted to sit with you, discuss mutual opportunities and live the Softigel experience.

Softigel by Procaps offers customers full-service, turnkey solutions in over-the-counter (OTC) and prescription products thanks to its softgel development and manufacturing expertise.

The company is focused on developing complex products encapsulated in softgel dosage forms and other delivery systems, high potency active pharmaceutical ingredients (API), differentiated OTC products and nutritional supplements in novel technologies.

Softigel offers a wide range of OTC monograph products in different softgel technologies, with flexible options including customised packaging solutions that range from pack development to full commercial-scale packaging with modern, state-of-the-art equipment to bring value and flexibility to our customers’ supply chains.

The company is one of the worlds´ largest softgel encapsulators, offering its customers deep gelatin and formulation expertise and regulatory support through all cycle stages. Its softgel facilities are approved by the US Food and Drug Administration (FDA), the Medicines and Healthcare Products Regulatory Agency (MHRA) and the Therapeutic Goods Administration (TGA).

At CPhI North America, Softigel seeks new OTC consumer healthcare, generic Rx and pharma customers with collaboration opportunities inside the US, other highly regulated markets or elsewhere worldwide, interested in the development of single to complex formulations in our advanced softgel dosage forms, clinical manufacturing, commercial manufacturing, tech-transfer, delivering the expertise you need and the innovation you demand.

Softigel will be present from 24April to 26 April at the Pennsylvania Convention Center, Stand # 1301.

In recent years, the development of highly potent molecules has become more frequent, and around 25% of the components that are being developed are classified...
Cannabis-based products are manufactured, mainly, from oils obtained from a synthetic way as Dronabinol or obtained from plants of genus Cannabis, as Cannabidiol (CBD) oils.
The present is an overview of the state-of-the-art for vegetarian soft capsules in terms of materials (sourcing and demand), applications, processing, products and a general...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy


Thank you for subscribing to Pharmaceutical Technology